SWEDENCARE AB (PUBL) Instrumento Inactivo
Empresa Swedencare AB (publ) Nasdaq Stockholm
Acciones
SE0008294078
Farmacéuticos
Resumen de negocios
Ventas por actividad
| SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Nutraceuticals
53,3
%
| 917 | 50,1 % | 1 240 | 53,3 % | +35,25 % |
Topicals/Dermatology
23,9
%
| 563 | 30,8 % | 556 | 23,9 % | -1,34 % |
ProDen PlaqueOff
11,6
%
| 179 | 9,8 % | 270 | 11,6 % | +50,51 % |
Other
7,0
%
| 79 | 4,3 % | 163 | 7,0 % | +107,21 % |
Pharma
4,2
%
| 92 | 5,0 % | 97 | 4,2 % | +5,29 % |
Ventas por región
| SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
North America
78,6
%
| 1 479 | 80,9 % | 1 827 | 78,6 % | +23,50 % |
Europe
18,6
%
| 173 | 9,5 % | 432 | 18,6 % | +149,51 % |
Rest of the World
2,8
%
| 7 | 0,4 % | 65 | 2,8 % | +798,72 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/14 | |
Jenny Graflind
DFI | Director of Finance/CFO | 48 | 01/01/17 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
| Director/Board Member | 65 | 01/01/23 | |
| Director/Board Member | 57 | 01/01/16 | |
| Director/Board Member | 61 | 01/01/19 | |
| Chief Executive Officer | 56 | 01/01/14 | |
| Chairman | 67 | 01/03/14 | |
| Director/Board Member | 60 | 01/01/22 | |
| Director/Board Member | 57 | 01/01/22 | |
Johan Bergdahl
BRD | Director/Board Member | 54 | 01/01/14 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 158 731 900 | 48 338 470 ( 30,45 %) | 0 | 30,45 % |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| -12,16 % | 79,1 mil M | |
| -3,15 % | 7131,04 M | |
| +21,25 % | 3579,85 M | |
| -9,18 % | 2928,01 M | |
| +16,05 % | 1693,11 M | |
| -8,50 % | 1187,94 M | |
| -33,05 % | 1108,32 M | |
| -36,85 % | 1052,5 M | |
| -27,92 % | 939 M |
